Kolltan Pharmaceuticals

Novel monoclonal antibody therapies targeting receptor tyrosine kinases to treat cancers.

Get a Demo and See the Full Profile

Get a demo today to see profiles of Kolltan Pharmaceuticals plus 5857 other startups.

Learn More

Learn More About Kolltan Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More

Companies We Work With